Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention-Reference-Cited by-同舟云学术

Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention

Published:2019-03-08 Issue:10 Volume:60 Page:1421-1429
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Loktev Anastasia,Lindner Thomas,Burger Eva-Maria,Altmann Annette,Giesel Frederik,Kratochwil Clemens,Debus Jürgen,Marmé Frederik,Jäger Dirk,Mier Walter,Haberkorn Uwe

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference17 articles.

1. Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy

2. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics;Puré;Oncogene.,2018

3. Targeting fibroblast activation protein in cancer: prospects and caveats;Busek;Front Biosci (Landmark Ed).,2018

4. Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers;Kilvaer;PLoS One.,2015

5. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: An update on new therapeutic methods;World Journal of Methodology;2024-12-20

2. Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives;European Journal of Medicinal Chemistry;2024-11

3. High Diagnostic Performance of 68Ga-FAPI-based Techniques in Female Cancer Detection: Systematic Review and Meta-Analysis;2024-09-08

4. [68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT;Frontiers in Oncology;2024-09-06

5. [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma;Pharmaceuticals;2024-08-29